136 related articles for article (PubMed ID: 12081123)
1. Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction.
Kongkanand A; Ratana-Olarn K; Wuddhikarn S; Luengwattanakit S; Tantiwong A; Ruengdilokrat S; Opanuraks J; Sripalakit S
J Med Assoc Thai; 2002 Feb; 85(2):223-8. PubMed ID: 12081123
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
Pangkahila WI
Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
[TBL] [Abstract][Full Text] [Related]
3. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
[TBL] [Abstract][Full Text] [Related]
6. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
[TBL] [Abstract][Full Text] [Related]
7. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
Amar E
Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
[TBL] [Abstract][Full Text] [Related]
8. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
Hellstrom WJ; Lewis RW
J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215
[No Abstract] [Full Text] [Related]
9. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.
Padma-Nathan H; Steidle C; Salem S; Tayse N; Yeager J; Harning R
Int J Impot Res; 2003 Feb; 15(1):10-7. PubMed ID: 12605235
[TBL] [Abstract][Full Text] [Related]
10. Transurethral alprostadil for the treatment of erectile dysfunction: results of a multicentre trial.
Li MK; Lim PH; Wong MY; Fok A; Chia SJ; Consigliere D; Adaikan PG; Moorthy P
Ann Acad Med Singap; 2000 Nov; 29(6):727-31. PubMed ID: 11269978
[TBL] [Abstract][Full Text] [Related]
11. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.
Benevides MD; Carson CC
J Urol; 2000 Mar; 163(3):785-7. PubMed ID: 10687977
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
[TBL] [Abstract][Full Text] [Related]
13. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
[TBL] [Abstract][Full Text] [Related]
14. [Transurethral alprostadil (MUSE) in erectile dysfunction].
Comeri G; Gianneo E; Nespoli R
Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
[TBL] [Abstract][Full Text] [Related]
15. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
Subramonian K; Weston PM
J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774
[No Abstract] [Full Text] [Related]
16. Optimizing the therapeutic approach of transurethral alprostadil.
Ekman P; Sjögren L; Englund G; Persson BE
BJU Int; 2000 Jul; 86(1):68-74. PubMed ID: 10886086
[TBL] [Abstract][Full Text] [Related]
17. MUSE therapy: preliminary clinical observations.
Werthman P; Rajfer J
Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
[TBL] [Abstract][Full Text] [Related]
18. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea.
Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC
Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635
[TBL] [Abstract][Full Text] [Related]
19. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
Raina R; Pahlajani G; Agarwal A; Zippe CD
BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
[TBL] [Abstract][Full Text] [Related]
20. Clinical conversations: intraurethral alprostadil (MUSE). Interview by Patricia Bates.
Lewis J; Helfrick B; Marzucco J
Urol Nurs; 1997 Dec; 17(4):159-61. PubMed ID: 9451246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
